Skip to main content
Premium Trial:

Request an Annual Quote

Pamela Pavco, Per Peterson

Premium
CytRx said that its subsidiary RXi Pharmaceuticals has appointed Pamela Pavco as its vice president of pharmaceutical development.
 
Previously, Pavcoheld various positions at RNAi drug developer Sirna Therapeutics, which was acquired by Merck this year. She holds a PhD in biochemistry from Virginia Commonwealth University, CytRx said.
 

 
Invitrogen has appointed Per Peterson to its board of directors.
 
Peterson recently retired as chairman of research and development at Johnson & Johnson. He holds a BM in medicine and a PhD in medicinal chemistry from the University of Uppsala.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.